CompletedNot Applicable

Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results

United States30 participantsStarted 2021-02-18

Plain-language summary

This clinical trial evaluates the feasibility of a linguistically-tailored mobile intervention, called CervixChat in improving the follow-up of patients with abnormal Papanicolaou (pap) test results. A text messaging program, such as CervixChat may support patients who need a colposcopy.

Who can participate

Age range21 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female, aged 21 to 65 years of age * Had received an abnormal Pap smear result * Scheduled colposcopy * Able to communicate with ease in English or Spanish * Have a cell phone with text (TXT) ability * Competent to give consent Exclusion Criteria: * Are pregnant at the time of recruitment * Display current evidence of positive invasive carcinoma of the cervix

What they're measuring

Patient Consent Rate

Timeframe: Up to 12 months

Study Completion Rate

Timeframe: Up to 12 months

Trial details

NCT IDNCT04821297

SponsorThomas Jefferson University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-31

View on ClinicalTrials.gov More Cervical Carcinoma trials